|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 15-05-06 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 15-04-29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Reents
PRN | Corporate Officer/Principal | 59 | - |
Dana Lee
PRN | Corporate Officer/Principal | 62 | 2013-01-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.94% | +8.20% | -4.77% | +1.97% | 46.2B | ||
| +5.79% | +16.17% | +423.57% | +634.63% | 38.71B | ||
| +1.12% | +15.18% | +22.65% | -12.71% | 31.9B | ||
| +3.61% | +6.69% | +19.80% | +62.38% | 31.12B | ||
| +8.02% | +5.23% | +17.67% | +35.36% | 23.77B | ||
| +1.13% | +15.66% | - | - | 16.2B | ||
| +1.45% | +17.35% | +70.37% | +127.60% | 15.05B | ||
| -1.13% | +9.05% | +12.03% | +18.95% | 13.74B | ||
| -0.60% | +6.32% | +104.23% | +96.28% | 13.42B | ||
| Average | +2.19% | +10.60% | +83.19% | +120.56% | 25.57B | |
| Weighted average by Cap. | +2.59% | +10.07% | +96.10% | +142.61% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















